Global Medical Second Opinion Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

Medical Second Opinion Service is the additional consultation taken by the patient after the primary diagnosis. The patient can opt for a medical second opinion if the patient feels dissatisfied with the diagnosis or if there is a need for further validation in case of some serious surgical procedures. There has been an upward surge in medical second opinion services mainly due to financial, health and legal costs involved in the treatment. The increased need for improved diagnosis and treatment planning, reducing the financial cost, and ease of interaction is expected to propel the market growth in the forecast period.

According to APO Research, The global Medical Second Opinion market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Medical Second Opinion is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Medical Second Opinion is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Medical Second Opinion is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Medical Second Opinion is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Medical Second Opinion include HCA Hospitals, AXA PPP Healthcare, Royal London Group, Helsana Group, Cleveland Clinic, Amradnet, Best Doctors Inc, Inova Care and Toranomon Hospital, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Medical Second Opinion, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Medical Second Opinion, also provides the revenue of main regions and countries. Of the upcoming market potential for Medical Second Opinion, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Medical Second Opinion revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Medical Second Opinion market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Medical Second Opinion revenue, projected growth trends, production technology, application and end-user industry.

Medical Second Opinion Segment by Company

HCA Hospitals
AXA PPP Healthcare
Royal London Group
Helsana Group
Cleveland Clinic
Amradnet
Best Doctors Inc
Inova Care
Toranomon Hospital
Keio University Hospital
Johns Hopkins Medicine
Penn Medicine
Oncology International Pvt. Ltd.
GrandOpinion
London Pain Clinic
Mondial Assistance
Medisense
Medo Asia Sdn. Bhd.

Medical Second Opinion Segment by Type

Hospitals
Medical Second Opinion Providing Companies
Health Insurance Companies

Medical Second Opinion Segment by Application

Cancer
Diabetes
Cardiac Disorders
Neurological Disorders
Ocular Disorders
Others

Medical Second Opinion Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Second Opinion market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Second Opinion and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Second Opinion.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Medical Second Opinion in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Second Opinion industry.
Chapter 3: Detailed analysis of Medical Second Opinion companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Second Opinionrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Market Analysis by Type
1.2.1 Global Medical Second Opinion Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Hospitals
1.2.3 Medical Second Opinion Providing Companies
1.2.4 Health Insurance Companies
1.3 Market Analysis by Application
1.3.1 Global Medical Second Opinion Market Size Growth Rate by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Cardiac Disorders
1.3.5 Neurological Disorders
1.3.6 Ocular Disorders
1.3.7 Others
1.4 Global Market Growth Prospects
1.5 Global Medical Second Opinion Growth Trends by Region
1.5.1 Global Medical Second Opinion Market Size by Region: 2020 VS 2024 VS 2031
1.5.2 Medical Second Opinion Market Size by Region (2020-2025)
1.5.3 Medical Second Opinion Market Size by Region (2026-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
1.8 Years Considered
2 Global Medical Second Opinion Market Dynamics
2.1 Medical Second Opinion Industry Trends
2.2 Medical Second Opinion Industry Drivers
2.3 Medical Second Opinion Industry Opportunities and Challenges
2.4 Medical Second Opinion Industry Restraints
3 Competitive Landscape by Company
3.1 Global Medical Second Opinion Revenue by Company (2020-2025)
3.2 Global Medical Second Opinion Players Revenue Ranking, 2023 VS 2024 VS 2025
3.3 Global Medical Second Opinion Key Company Head office and Area Served
3.4 Global Medical Second Opinion Company, Product Type & Application
3.5 Global Medical Second Opinion Company Establishment Date
3.6 Market Competitive Analysis
3.6.1 Global Medical Second Opinion Market CR5 and HHI
3.6.2 Global Top 5 and 10 Medical Second Opinion Players Market Share by Revenue in 2024
3.6.3 2024 Medical Second Opinion Tier 1, Tier 2, and Tier 3
4 Medical Second Opinion Market by Type
4.1 Global Medical Second Opinion Market Size by Type (2020 VS 2024 VS 2031)
4.2 Global Medical Second Opinion Market Size by Type (2020-2031)
4.3 Global Medical Second Opinion Market Size Share by Type (2020-2031)
5 Medical Second Opinion Market by Application
5.1 Global Medical Second Opinion Market Size by Application (2020 VS 2024 VS 2031)
5.2 Global Medical Second Opinion Market Size by Application (2020-2031)
5.3 Global Medical Second Opinion Market Size Share by Application (2020-2031)
6 Company Profiles
6.1 HCA Hospitals
6.1.1 HCA Hospitals Comapny Information
6.1.2 HCA Hospitals Business Overview
6.1.3 HCA Hospitals Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2020-2025)
6.1.4 HCA Hospitals Medical Second Opinion Product Portfolio
6.1.5 HCA Hospitals Recent Developments
6.2 AXA PPP Healthcare
6.2.1 AXA PPP Healthcare Comapny Information
6.2.2 AXA PPP Healthcare Business Overview
6.2.3 AXA PPP Healthcare Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2020-2025)
6.2.4 AXA PPP Healthcare Medical Second Opinion Product Portfolio
6.2.5 AXA PPP Healthcare Recent Developments
6.3 Royal London Group
6.3.1 Royal London Group Comapny Information
6.3.2 Royal London Group Business Overview
6.3.3 Royal London Group Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2020-2025)
6.3.4 Royal London Group Medical Second Opinion Product Portfolio
6.3.5 Royal London Group Recent Developments
6.4 Helsana Group
6.4.1 Helsana Group Comapny Information
6.4.2 Helsana Group Business Overview
6.4.3 Helsana Group Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2020-2025)
6.4.4 Helsana Group Medical Second Opinion Product Portfolio
6.4.5 Helsana Group Recent Developments
6.5 Cleveland Clinic
6.5.1 Cleveland Clinic Comapny Information
6.5.2 Cleveland Clinic Business Overview
6.5.3 Cleveland Clinic Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2020-2025)
6.5.4 Cleveland Clinic Medical Second Opinion Product Portfolio
6.5.5 Cleveland Clinic Recent Developments
6.6 Amradnet
6.6.1 Amradnet Comapny Information
6.6.2 Amradnet Business Overview
6.6.3 Amradnet Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2020-2025)
6.6.4 Amradnet Medical Second Opinion Product Portfolio
6.6.5 Amradnet Recent Developments
6.7 Best Doctors Inc
6.7.1 Best Doctors Inc Comapny Information
6.7.2 Best Doctors Inc Business Overview
6.7.3 Best Doctors Inc Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2020-2025)
6.7.4 Best Doctors Inc Medical Second Opinion Product Portfolio
6.7.5 Best Doctors Inc Recent Developments
6.8 Inova Care
6.8.1 Inova Care Comapny Information
6.8.2 Inova Care Business Overview
6.8.3 Inova Care Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2020-2025)
6.8.4 Inova Care Medical Second Opinion Product Portfolio
6.8.5 Inova Care Recent Developments
6.9 Toranomon Hospital
6.9.1 Toranomon Hospital Comapny Information
6.9.2 Toranomon Hospital Business Overview
6.9.3 Toranomon Hospital Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2020-2025)
6.9.4 Toranomon Hospital Medical Second Opinion Product Portfolio
6.9.5 Toranomon Hospital Recent Developments
6.10 Keio University Hospital
6.10.1 Keio University Hospital Comapny Information
6.10.2 Keio University Hospital Business Overview
6.10.3 Keio University Hospital Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2020-2025)
6.10.4 Keio University Hospital Medical Second Opinion Product Portfolio
6.10.5 Keio University Hospital Recent Developments
6.11 Johns Hopkins Medicine
6.11.1 Johns Hopkins Medicine Comapny Information
6.11.2 Johns Hopkins Medicine Business Overview
6.11.3 Johns Hopkins Medicine Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2020-2025)
6.11.4 Johns Hopkins Medicine Medical Second Opinion Product Portfolio
6.11.5 Johns Hopkins Medicine Recent Developments
6.12 Penn Medicine
6.12.1 Penn Medicine Comapny Information
6.12.2 Penn Medicine Business Overview
6.12.3 Penn Medicine Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2020-2025)
6.12.4 Penn Medicine Medical Second Opinion Product Portfolio
6.12.5 Penn Medicine Recent Developments
6.13 Oncology International Pvt. Ltd.
6.13.1 Oncology International Pvt. Ltd. Comapny Information
6.13.2 Oncology International Pvt. Ltd. Business Overview
6.13.3 Oncology International Pvt. Ltd. Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2020-2025)
6.13.4 Oncology International Pvt. Ltd. Medical Second Opinion Product Portfolio
6.13.5 Oncology International Pvt. Ltd. Recent Developments
6.14 GrandOpinion
6.14.1 GrandOpinion Comapny Information
6.14.2 GrandOpinion Business Overview
6.14.3 GrandOpinion Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2020-2025)
6.14.4 GrandOpinion Medical Second Opinion Product Portfolio
6.14.5 GrandOpinion Recent Developments
6.15 London Pain Clinic
6.15.1 London Pain Clinic Comapny Information
6.15.2 London Pain Clinic Business Overview
6.15.3 London Pain Clinic Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2020-2025)
6.15.4 London Pain Clinic Medical Second Opinion Product Portfolio
6.15.5 London Pain Clinic Recent Developments
6.16 Mondial Assistance
6.16.1 Mondial Assistance Comapny Information
6.16.2 Mondial Assistance Business Overview
6.16.3 Mondial Assistance Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2020-2025)
6.16.4 Mondial Assistance Medical Second Opinion Product Portfolio
6.16.5 Mondial Assistance Recent Developments
6.17 Medisense
6.17.1 Medisense Comapny Information
6.17.2 Medisense Business Overview
6.17.3 Medisense Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2020-2025)
6.17.4 Medisense Medical Second Opinion Product Portfolio
6.17.5 Medisense Recent Developments
6.18 Medo Asia Sdn. Bhd.
6.18.1 Medo Asia Sdn. Bhd. Comapny Information
6.18.2 Medo Asia Sdn. Bhd. Business Overview
6.18.3 Medo Asia Sdn. Bhd. Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2020-2025)
6.18.4 Medo Asia Sdn. Bhd. Medical Second Opinion Product Portfolio
6.18.5 Medo Asia Sdn. Bhd. Recent Developments
7 North America
7.1 North America Medical Second Opinion Market Size (2020-2031)
7.2 North America Medical Second Opinion Market Size by Type
7.2.1 North America Medical Second Opinion Market Size by Type (2020-2025)
7.2.2 North America Medical Second Opinion Market Size by Type (2026-2031)
7.2.3 North America Medical Second Opinion Market Share by Type (2020-2031)
7.3 North America Medical Second Opinion Market Size by Application
7.3.1 North America Medical Second Opinion Market Size by Application (2020-2025)
7.3.2 North America Medical Second Opinion Market Size by Application (2026-2031)
7.3.3 North America Medical Second Opinion Market Share by Application (2020-2031)
7.4 North America Medical Second Opinion Market Size by Country
7.4.1 North America Medical Second Opinion Market Size by Country (2020 VS 2024 VS 2031)
7.4.2 North America Medical Second Opinion Market Size by Country (2020-2025)
7.4.3 North America Medical Second Opinion Market Size by Country (2026-2031)
7.4.4 North America Medical Second Opinion Market Share by Country (2020-2031)
7.4.5 United States
7.4.6 Canada
7.4.7 Mexico
8 Europe
8.1 Europe Medical Second Opinion Market Size (2020-2031)
8.2 Europe Medical Second Opinion Market Size by Type
8.2.1 Europe Medical Second Opinion Market Size by Type (2020-2025)
8.2.2 Europe Medical Second Opinion Market Size by Type (2026-2031)
8.2.3 Europe Medical Second Opinion Market Share by Type (2020-2031)
8.3 Europe Medical Second Opinion Market Size by Application
8.3.1 Europe Medical Second Opinion Market Size by Application (2020-2025)
8.3.2 Europe Medical Second Opinion Market Size by Application (2026-2031)
8.3.3 Europe Medical Second Opinion Market Share by Application (2020-2031)
8.4 Europe Medical Second Opinion Market Size by Country
8.4.1 Europe Medical Second Opinion Market Size by Country (2020 VS 2024 VS 2031)
8.4.2 Europe Medical Second Opinion Market Size by Country (2020-2025)
8.4.3 Europe Medical Second Opinion Market Size by Country (2026-2031)
8.4.4 Europe Medical Second Opinion Market Share by Country (2020-2031)
8.4.5 Germany
8.4.6 France
8.4.7 U.K.
8.4.8 Italy
8.4.9 Russia
8.4.10 Nordic Countries
9 China
9.1 China Medical Second Opinion Market Size (2020-2031)
9.2 China Medical Second Opinion Market Size by Type
9.2.1 China Medical Second Opinion Market Size by Type (2020-2025)
9.2.2 China Medical Second Opinion Market Size by Type (2026-2031)
9.2.3 China Medical Second Opinion Market Share by Type (2020-2031)
9.3 China Medical Second Opinion Market Size by Application
9.3.1 China Medical Second Opinion Market Size by Application (2020-2025)
9.3.2 China Medical Second Opinion Market Size by Application (2026-2031)
9.3.3 China Medical Second Opinion Market Share by Application (2020-2031)
10 Asia (Excluding China)
10.1 Asia Medical Second Opinion Market Size (2020-2031)
10.2 Asia Medical Second Opinion Market Size by Type
10.2.1 Asia Medical Second Opinion Market Size by Type (2020-2025)
10.2.2 Asia Medical Second Opinion Market Size by Type (2026-2031)
10.2.3 Asia Medical Second Opinion Market Share by Type (2020-2031)
10.3 Asia Medical Second Opinion Market Size by Application
10.3.1 Asia Medical Second Opinion Market Size by Application (2020-2025)
10.3.2 Asia Medical Second Opinion Market Size by Application (2026-2031)
10.3.3 Asia Medical Second Opinion Market Share by Application (2020-2031)
10.4 Asia Medical Second Opinion Market Size by Country
10.4.1 Asia Medical Second Opinion Market Size by Country (2020 VS 2024 VS 2031)
10.4.2 Asia Medical Second Opinion Market Size by Country (2020-2025)
10.4.3 Asia Medical Second Opinion Market Size by Country (2026-2031)
10.4.4 Asia Medical Second Opinion Market Share by Country (2020-2031)
10.4.5 Japan
10.4.6 South Korea
10.4.7 Taiwan
10.4.8 Southeast Asia
10.4.9 India
10.4.10 Australia
11 South America, Middle East & Africa
11.1 South America, Middle East & Africa Medical Second Opinion Market Size (2020-2031)
11.2 South America, Middle East & Africa Medical Second Opinion Market Size by Type
11.2.1 South America, Middle East & Africa Medical Second Opinion Market Size by Type (2020-2025)
11.2.2 South America, Middle East & Africa Medical Second Opinion Market Size by Type (2026-2031)
11.2.3 South America, Middle East & Africa Medical Second Opinion Market Share by Type (2020-2031)
11.3 South America, Middle East & Africa Medical Second Opinion Market Size by Application
11.3.1 South America, Middle East & Africa Medical Second Opinion Market Size by Application (2020-2025)
11.3.2 South America, Middle East & Africa Medical Second Opinion Market Size by Application (2026-2031)
11.3.3 South America, Middle East & Africa Medical Second Opinion Market Share by Application (2020-2031)
11.4 South America, Middle East & Africa Medical Second Opinion Market Size by Country
11.4.1 South America, Middle East & Africa Medical Second Opinion Market Size by Country (2020 VS 2024 VS 2031)
11.4.2 South America, Middle East & Africa Medical Second Opinion Market Size by Country (2020-2025)
11.4.3 South America, Middle East & Africa Medical Second Opinion Market Size by Country (2026-2031)
11.4.4 South America, Middle East & Africa Medical Second Opinion Market Share by Country (2020-2031)
11.4.5 Brazil
11.4.6 South Africa
11.4.7 Saudi Arabia
11.4.8 Turkey
11.4.9 Argentina
11.4.9 UAE
11.4.9 Egypt
11.4.9 Chile
12 Concluding Insights
13 Appendix
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
13.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings